AstraZeneca PLC
I · KI-Analyse
Kurzfassung
AstraZeneca develops and sells prescription drugs for cancer (Tagrisso, Lynparza, Imfinzi, Enhertu), heart disease and diabetes (Farxiga, Brilinta, Crestor), respiratory conditions (Symbicort, Fasenra, Breztri), and rare diseases (Soliris, Ultomiris, Strensiq) [Company Overview]. The company sells through distributors and local offices across the UK, Americas, Europe, Asia, Africa, and Australasia, serving primary care doctors and specialists [Company Overview]. Strategic partnerships with Tempus, Pathos, and CSPC Pharmaceutical aim to advance AI-driven oncology research and novel oral drug candidates [Company Overview].
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, UK, with 96,100 employees focused on discovering, developing, and commercializing prescription medicines across oncology, cardiovascular, respiratory, immunology, and rare diseases [Company Overview]. The company generated $58.7B in revenue with strong margins (81.9% gross, 24.0% operating) and a solid financial health score of 8.9/10 [Yahoo Finance] [Sentinellis calculation]. A recent 1:2 stock split on February 2, 2026, doubled the share count, making per-share historical comparisons require adjustment [EODHD].
AstraZeneca is financially healthy with strong revenue growth, excellent margins, and manageable debt [Yahoo Finance].
Sentinellis-Score
8,9/10
Finanziell gesund
Marktkapitalisierung
$287,2B
Umsatz (12 Monate)
$58,7B
Erklärt
Wie wir diese Zahlen lesen
Verständliche Leitfäden · ohne Konto
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LesenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LesenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LesenPremium · kostenlos mit jedem Konto
Patent cliffs pose ongoing risk — when blockbuster drug patents expire, generic competition can drastically reduce revenue for those products, requiring a strong pipeline to offset losses.
Risiken
5
Chancen
5
Warnsignale
3
Führung
10
12 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.
Vollständige AstraZeneca PLC-Analyse freischalten
Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.
- 5 Risiken, 5 Chancen und 3 Warnsignale — jeweils mit Quelle
- Über 100 Finanzkennzahlen mit Charts und Vergleichen
- Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
- Führungsteam und Vergütung
- PDF-Export für offline
III · Ähnliche Unternehmen
Das könnte Sie auch interessieren
Gleicher Sektor · Gesundheitswesen — oder vergleichbare Finanzlage
Auf Ihre Watchlist setzen?